General Information
Product name
Bortezomib for Injection 3.5 mg/Vial
Chemical name
Mixture
CAS No.
179324-69-7
1.2.1 Relevant identified uses
pharmaceutical product used as Antineoplastic drug
Manufacturer Name
MSN Laboratories Private Limited Formulation Division, Unit
Icons in SDS
Company Information
company name
MSN Laboratories Private Limited Formulation Division, Unit
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H360F
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
OSHA Exposure: Inhalation, Ingestion, Skin contact, Eye contact Target Organs: Eye, skin, mucous membranes, gastrointestinal system Acute Effects: May cause eye irritation., May cause skin irritation., May cause gastrointestinal effects., Signs and symptoms may include nausea, vomiting, diarrhea, constipation, cramps, and loss of appetite.
Potential chronic health
May cause skin irritation
Precautionary statements
- P201 Obtain special instructions before use. - P260 Do not breathe dust - P281 Use personal protective equipment as required. - P308 + P313 IF exposed or concerned: Get medical advice/attention. Additional Health Information - Some components of this product are considered potential reproductive effectors at high dosage. Refer to Section 11 (Toxicological information) for additional information on this product. - The most common dose-dependent adverse effects associated with therapeutic treatments include diarrhea, nausea, vomiting, sores in mouth and throat, abdominal pain, constipation, loss of appetite, dehydration, rash and dry, itchy or discolored skin. - Additional effects may include nail problems, hair loss, tiredness, weakness, dizziness, headache, fever, chest, back, joint and muscle pain, trouble sleeping, taste problems and palms of the hands or soles of the feet tingle, become painful or swollen. Note: Cytostatic in general have to be classified as potentially carcinogenic, teratogenic and mutagenic. During handling any occupational exposure as well as environmental contamination have to be avoided.
2.1 Classification of the substance or mixture
Germ cell mutagenicity (Category 2) H341 Suspected of causing genetic defects. Carcinogenicity (Category 1B)H350 May cause cancer. D Reproductive toxicity (Category 1B)H360D May damage the unborn child. F Reproductive toxicity (Category 1B) H360F May damage fertility. Signalword: Danger Label
